Podcast

Alexander Ford, MD, Speaks on Amitriptyline as a Potentially Effective Option for IBS

02/09/2024

The results of the ATLANTIS trial showed that patients taking amitriptyline were almost twice as likely to report an overall improvement in symptoms of irritable bowel syndrome as those taking a placebo. Co-chief investigator Alexander Ford, MD, explains the results and the implications.

Alexander Ford, MD, is a professor of gastroenterology at the University of Leeds and an honorary consultant gastroenterologist at Leeds Teaching Hospitals NHS Trust in Leeds, UK.

© 2024 HMP Global. All Rights Reserved.

Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of the Gastroenterology Learning Network or HMP Global, their employees, and affiliates.

Sign up for our e-Newsletters

Gastroenterology Newsletter

News

Novel AI System Shows Success in Detection of Adenomas

08/27/2024

Jessica Garlewicz ;

CAD-EYE detection system significantly improved the number of adenomas detected per colonoscopy without extending the procedure time, according to a recent report.

CAD-EYE detection system...

08/27/2024

Gastroenterology

News

Implementation of Fecal Immunochemical Test-Based Program in Colorectal Cancer Screening

08/20/2024

Jessica Garlewicz ;

Investigators studied whether fecal immunochemical test programs might be feasible options for improving colorectal cancer screening in areas with limited resources.

Investigators studied whether...

08/20/2024

Gastroenterology

News

Low-Dose Aspirin and Prevention of Colorectal Cancer

08/14/2024

Jessica Garlewicz ;

Results of a new study showed that low-dose aspirin use is associated with a lower risk of colorectal cancer.

Results of a new study showed...

08/14/2024

Gastroenterology

News

FIT Screening Associated With Lower Risk of Death From CRC

08/06/2024

Jessica Garlewicz ;

Findings of a new study support the role of fecal immunochemical testing in reducing mortality from colorectal cancer, researchers report.

Findings of a new study support...

08/06/2024

Gastroenterology

News

FDA Approves First Blood Test for Primary CRC Screening

07/30/2024

Rebecca Mashaw ;

Shield is the first blood test cleared for primary colorectal cancer screening that meets Medicare performance requirements.

Shield is the first blood test...

07/30/2024

Gastroenterology

News

Colorectal Cancer Risk Higher Among Patients WIth PSC, With or Without IBD

07/24/2024

Jolynn Tumolo ;

Extended screening and surveillance are recommended for all patients with primary sclerosing cholangitis, but those with comorbid inflammatory bowel disease are at highest risk.

Extended screening and...

07/24/2024

Gastroenterology

News

Ultraprocessed Food Linked to Elevated Risk of CRC

07/24/2024

Jolynn Tumolo ;

C olorectal cancer, colon cancer, and noncardia gastric cancer were found to be associated with high consumption of ultraprocessed foods, according to recent research.

C olorectal cancer, colon...

07/24/2024

Gastroenterology